Biological Sample Handling Market by Type, Product, End-Use, Application

Description

List of Tables

[186 Pages Report] The Biological Sample Handling Market size was estimated at USD 18.62 billion in 2023 and expected to reach USD 19.85 billion in 2024, at a CAGR 6.47% to reach USD 28.88 billion by 2030.

Biological sample handling refers to collecting, storing, processing, and transporting biological materials, such as blood, tissue, saliva, or any other organismal specimen, in a way that preserves the integrity and minimizes contamination or degradation of the sample. This process is crucial for ensuring the reliability of biological research, clinical diagnostics, and therapeutic interventions. It encompasses a wide range of protocols and procedures tailored to the specific requirements of the biological material, including temperature control, contamination prevention, and legal and ethical compliance regarding sample collection and use. An increase in research and development (R&D) activities, especially in genomics, proteomics, and personalized medicine, drives the demand for sophisticated sample-handling solutions to ensure sample integrity and reliability. However, the strict regulations associated with biological sample handling are a significant challenge the key players face. Companies adhere to government regulations to remain sustainable and agile within the global space. Moreover, technological advancements in automation and cryopreservation have revolutionized the handling of biological samples. Automated systems reduce human error and increase throughput, while advances in cryopreservation techniques have extended the viability of samples, thereby supporting longer-term studies.

KEY MARKET STATISTICS
Base Year [2023]	USD 18.62 billion
Estimated Year [2024]	USD 19.85 billion
Forecast Year [2030]	USD 28.88 billion
CAGR (%)	6.47%

Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation

In biological sample handling, various products are essential for the accurate and efficient collection, transport, and analysis of specimens. Among these critical products are blood collection kits designed to gather blood samples safely and effectively for various diagnostics. Swabs, including nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs, are specialized tools used for the collection of samples from specific anatomical locations, offering a minimally invasive means to acquire cells or fluids for testing, notably in the detection of viral pathogens. Additionally, viral transport media plays a pivotal role in preserving viral samples during transport, ensuring the integrity and viability of the specimens until analysis. Each product is designed with precision and adherence to stringent health standards to facilitate accurate diagnostics and research, highlighting the importance of quality and reliability in biological sample handling.

End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management

Diagnostic centers are pivotal venues for specialized testing and analysis of biological samples. These facilities are essential for accurate disease diagnosis and integral to medical decision-making. Homecare represents an emerging segment reflective of a broader shift towards patient-centric healthcare models. In this domain, innovations such as at-home testing kits facilitate individuals' collection and handling of biological samples in the comfort and privacy of their homes, thereby promoting proactive health management. Moreover, hospitals & clinics are traditional and vital settings for biological sample handling. These institutions are at the forefront of patient care, with the collection, analysis, and storage of samples supporting a wide range of clinical needs, from routine check-ups to complex surgeries.

Regional Insights

In the Americas, biological sample handling is highly regulated, strongly emphasizing compliance with FDA regulations and guidelines. Recent patents have focused on improving the accuracy and efficiency of sample processing. Investments in biobanking and personalized medicine have driven the demand for advanced sample-handling solutions in this region. Customers in America prioritize reliability and quality, with a growing interest in automation and integrated systems. On the other hand, in the EMEA, the regulatory environment is stringent, with a focus on data protection and patient privacy impacting sample handling practices. Investments in biobanks and translational research are widespread in the region. Moreover, the Asia-Pacific region is witnessing a dynamic shift in the biological sample handling market, characterized by significant growth due to rising investments in biobanking, an expanding biopharmaceutical sector, and an increasing emphasis on research and development activities. The proliferation of chronic diseases and the urgent need for personalized medicine are significant drivers propelling advancements in biological sample-handling techniques.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biological Sample Handling Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Sample Handling Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Cellular & Genetic Material
- Saliva Samples
- Stool Samples
- Urine Samples

Product
- Blood Collection Kits
- Swabs
  - Nasal Swabs
  - Nasopharyngeal Swabs
  - Oropharyngeal Swabs

Viral Transport Media

End-Use
- Diagnostic Centers
- Homecare
- Hospitals & Clinics

Application
- Diagnostics
- Research

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biological Sample Handling Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Sample Handling Market?

3. What are the technology trends and regulatory frameworks in the Biological Sample Handling Market?

4. What is the market share of the leading vendors in the Biological Sample Handling Market?

5. Which modes and strategic moves are suitable for entering the Biological Sample Handling Market?

Product Code: MRR-757B1C9CB0B6

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing need for fluid sample management and handling in personalized healthcare
  - 5.1.1.2. Growing demand from genomics and proteomics and the rise in biobanking practices
  - 5.1.1.3. Exponential growth of biomarker analysis and the need for sophisticated sample handling
- 5.1.2. Restraints
  - 5.1.2.1. Strict regulations associated with biological sample handling
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing investment in life sciences R&D activities
  - 5.1.3.2. Technological advancements and innovations in sample handling
- 5.1.4. Challenges
  - 5.1.4.1. Complexity associated with operations and need for specific handling protocols
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
- 5.2.2. End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Biological Sample Handling Market, by Type

6.1. Introduction
6.2. Cellular & Genetic Material
6.3. Saliva Samples
6.4. Stool Samples
6.5. Urine Samples

7. Biological Sample Handling Market, by Product

7.1. Introduction
7.2. Blood Collection Kits
7.3. Swabs
7.4. Viral Transport Media

8. Biological Sample Handling Market, by End-Use

8.1. Introduction
8.2. Diagnostic Centers
8.3. Homecare
8.4. Hospitals & Clinics

9. Biological Sample Handling Market, by Application

9.1. Introduction
9.2. Diagnostics
9.3. Research

10. Americas Biological Sample Handling Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biological Sample Handling Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Handling Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. MedLife to Transport Lab Samples with Drones
- 13.3.2. BioLizard and Parean Biotechnologies Announce Partnership
- 13.3.3. MolGen Acquires Synchron Lab Automation
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio